Characteristics and outcome of COVID-19 patients admitted to the ICU: a nationwide cohort study on the comparison between the consecutive stages of the COVID-19 pandemic in the Netherlands, an update
- PMID: 38228972
- PMCID: PMC10792150
- DOI: 10.1186/s13613-023-01238-2
Characteristics and outcome of COVID-19 patients admitted to the ICU: a nationwide cohort study on the comparison between the consecutive stages of the COVID-19 pandemic in the Netherlands, an update
Abstract
Background: Previously, we reported a decreased mortality rate among patients with COVID-19 who were admitted at the ICU during the final upsurge of the second wave (February-June 2021) in the Netherlands. We examined whether this decrease persisted during the third wave and the phases with decreasing incidence of COVID-19 thereafter and brought up to date the information on patient characteristics.
Methods: Data from the National Intensive Care Evaluation (NICE)-registry of all COVID-19 patients admitted to an ICU in the Netherlands were used. Patient characteristics and rates of in-hospital mortality (the primary outcome) during the consecutive periods after the first wave (periods 2-9, May 25, 2020-January 31, 2023) were compared with those during the first wave (period 1, February-May 24, 2020).
Results: After adjustment for patient characteristics and ICU occupancy rate, the mortality risk during the initial upsurge of the third wave (period 6, October 5, 2021-January, 31, 2022) was similar to that of the first wave (ORadj = 1.01, 95%-CI [0.88-1.16]). The mortality rates thereafter decreased again (e.g., period 9, October 5, 2022-January, 31, 2023: ORadj = 0.52, 95%-CI [0.41-0.66]). Among the SARS-CoV-2 positive patients, there was a huge drop in the proportion of patients with COVID-19 as main reason for ICU admission: from 88.2% during the initial upsurge of the third wave to 51.7%, 37.3%, and 41.9% for the periods thereafter. Restricting the analysis to these patients did not modify the results on mortality.
Conclusions: The results show variation in mortality rates among critically ill COVID-19 patients across the calendar time periods that is not explained by differences in case-mix and ICU occupancy rates or by varying proportions of patients with COVID-19 as main reason for ICU admission. The consistent increase in mortality during the initial, rising phase of each separate wave might be caused by the increased virulence of the contemporary virus strain and lacking immunity to the new strain, besides unmeasured patient-, treatment- and healthcare system characteristics.
Keywords: COVID-19; Coronavirus; Critical Care; Intensive Care; Mortality; Outcome.
© 2024. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Characteristics and outcome of COVID-19 patients admitted to the ICU: a nationwide cohort study on the comparison between the first and the consecutive upsurges of the second wave of the COVID-19 pandemic in the Netherlands.Ann Intensive Care. 2022 Jan 13;12(1):5. doi: 10.1186/s13613-021-00978-3. Ann Intensive Care. 2022. PMID: 35024981 Free PMC article.
-
Mortality comparison between the first and second/third waves among 3,795 critical COVID-19 patients with pneumonia admitted to the ICU: A multicentre retrospective cohort study.Lancet Reg Health Eur. 2021 Dec;11:100243. doi: 10.1016/j.lanepe.2021.100243. Epub 2021 Nov 4. Lancet Reg Health Eur. 2021. PMID: 34751263 Free PMC article.
-
Near real-time observation reveals increased prevalence of young patients in the ICU during the emerging third SARS-CoV-2 wave in Switzerland.Swiss Med Wkly. 2021 Jul 21;151:Swiss Med Wkly. 2021;151:w20553. doi: 10.4414/smw.2021.20553. eCollection 2021 Jul 19. Swiss Med Wkly. 2021. PMID: 34291810
-
Incidence and mortality due to thromboembolic events during the COVID-19 pandemic: Multi-sourced population-based health records cohort study.Thromb Res. 2021 Jun;202:17-23. doi: 10.1016/j.thromres.2021.03.006. Epub 2021 Mar 8. Thromb Res. 2021. PMID: 33711754 Free PMC article.
-
An observational study on factors associated with ICU mortality in Covid-19 patients and critical review of the literature.Sci Rep. 2023 May 13;13(1):7804. doi: 10.1038/s41598-023-34613-x. Sci Rep. 2023. PMID: 37179397 Free PMC article. Review.
Cited by
-
In-hospital mortality in patients admitted to Australian intensive care units with COVID-19 between 2020 and 2024.Crit Care Resusc. 2025 Feb 28;27(1):100094. doi: 10.1016/j.ccrj.2024.11.003. eCollection 2025 Mar. Crit Care Resusc. 2025. PMID: 40109285 Free PMC article.
-
The Impact of the COVID-19 Omicron Variant on Immunocompromised Patients: ICU Admissions and Increased Mortality.Infect Dis Ther. 2025 Apr;14(4):881-888. doi: 10.1007/s40121-025-01122-5. Epub 2025 Mar 14. Infect Dis Ther. 2025. PMID: 40085166 Free PMC article.
-
The Maastricht Intensive Care COVID Cohort: A Critical Appraisal of the Predefined Research Questions.Crit Care Explor. 2025 Feb 3;7(2):e1211. doi: 10.1097/CCE.0000000000001211. eCollection 2025 Feb 1. Crit Care Explor. 2025. PMID: 39899442 Free PMC article.
-
Longitudinal Metabolomics Reveals Metabolic Dysregulation Dynamics in Patients with Severe COVID-19.Metabolites. 2024 Nov 25;14(12):656. doi: 10.3390/metabo14120656. Metabolites. 2024. PMID: 39728437 Free PMC article.
-
Analysis of six consecutive waves of ICU-admitted COVID-19 patients: key findings and insights from a Portuguese population.Geroscience. 2025 Apr;47(2):2399-2422. doi: 10.1007/s11357-024-01410-x. Epub 2024 Nov 14. Geroscience. 2025. PMID: 39538084 Free PMC article.
References
-
- Contou D, Fraisse M, Pajot O, Tirolien JA, Mentec H, Plantefeve G. Comparison between first and second wave among critically ill COVID-19 patients admitted to a French ICU: no prognostic improvement during the second wave? Crit Care. 2021;25(1):3. doi: 10.1186/s13054-020-03449-6. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous